Dual inhibition of CDK4 and FYN leads to selective cell death in KRAS-mutant colorectal cancer

被引：8
|
作者：
Wang, Yan [1 ]
Lin, Rongjie [1 ,2 ]
Ling, Huan [1 ]
Ke, Yuan [1 ]
Zeng, Yangyang [1 ]
Xiong, Yudi [1 ]
Zhou, Qian [1 ]
Zhou, Fuxiang [1 ,3 ]
Zhou, Yunfeng [1 ,3 ]
机构：
[1] Hubei Key Lab Tumor Biol Behav, Wuhan, Hubei, Peoples R China
[2] Fujian Med Univ, Fujian Canc Hosp, Dept Radiat Oncol, Canc Hosp, Fuzhou, Fujian, Peoples R China
[3] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan, Hubei, Peoples R China
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2019年 / 4卷 / 1期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1038/s41392-019-0088-z
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Dual inhibition of CDK4 and FYN leads to selective cell death in KRAS-mutant colorectal cancer
    Yan Wang
    Rongjie Lin
    Huan Ling
    Yuan Ke
    Yangyang Zeng
    Yudi Xiong
    Qian Zhou
    Fuxiang Zhou
    Yunfeng Zhou
    Signal Transduction and Targeted Therapy, 4
  • [2] Dual inhibition of VEGF and PARP suppresses KRAS-mutant colorectal cancer
    Zhong, Longhui
    Wang, Rong
    Wang, Yanxia
    Peng, Shunli
    Ma, Yueyun
    Ding, Sijie
    Yang, Hong
    Chen, Shiyu
    Luo, Xiaoqing
    Wang, Wei
    NEOPLASIA, 2020, 22 (09): : 365 - 375
  • [3] Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy That Cotargets MEK and CDK4/6
    Ziemke, Elizabeth K.
    Dosch, Joseph S.
    Maust, Joel D.
    Shettigar, Amrith
    Sen, Ananda
    Welling, Theodore H.
    Hardiman, Karin M.
    Sebolt-Leopold, Judith S.
    CLINICAL CANCER RESEARCH, 2016, 22 (02) : 405 - 414
  • [4] Combination therapies with CDK4/6 inhibitors to treat KRAS-mutant pancreatic cancer
    Goodwin, Craig M.
    Javaid, Sehrish
    Waters, Andrew M.
    Papke, Bjoern
    Yang, Runying
    Pierobon, Mariaelena
    Freed, Daniel M.
    Roberts, Patrick J.
    Cox, Adrienne D.
    Wood, Kris C.
    Petricoin, Emanuel F.
    Mcree, Autumn J.
    Der, Channing J.
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer
    Goodwin, Craig M.
    Waters, Andrew M.
    Klomp, Jennifer E.
    Javaid, Sehrish
    Bryant, Kirsten L.
    Stalnecker, Clint A.
    Drizyte-Miller, Kristina
    Papke, Bjoern
    Yang, Runying
    Amparo, Amber M.
    Ozkan-Dagliyan, Irem
    Baldelli, Elisa
    Calvert, Valerie
    Pierobon, Mariaelena
    Sorrentino, Jessica A.
    Beelen, Andrew P.
    Bublitz, Natalie
    Luethen, Mareen
    Wood, Kris C.
    Petricoin III, Emanuel F.
    Sers, Christine
    McRee, Autumn J.
    Cox, Adrienne D.
    Der, Channing J.
    CANCER RESEARCH, 2023, 83 (01) : 141 - 157
  • [6] Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6
    Sorokin, Alexey V.
    Marie, Preeti Kanikarla
    Bitner, Lea
    Syed, Muddassir
    Woods, Melanie
    Manyam, Ganiraju
    Kwong, Lawrence N.
    Johnson, Benny
    Morris, Van K.
    Jones, Philip
    Menter, David G.
    Lee, Michael S.
    Kopetz, Scott
    CANCER RESEARCH, 2022, 82 (18) : 3335 - 3344
  • [7] Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer
    Padhye, Aparna
    Konen, Jessica M.
    Rodriguez, B. Leticia
    Fradette, Jared J.
    Ochieng, Joshua K.
    Diao, Lixia
    Wang, Jing
    Lu, Wei
    Solis, Luisa S.
    Batra, Harsh
    Raso, Maria G.
    Peoples, Michael D.
    Minelli, Rosalba
    Carugo, Alessandro
    Bristow, Christopher A.
    Gibbons, Don L.
    JCI INSIGHT, 2021, 6 (17)
  • [8] ERK MAPK inhibition enhances the immunogenicity of KRAS-mutant colorectal cancer.
    Ryan, Meagan B.
    de la Cruz, Ferran Fece
    Ahronian, Leanne G.
    Phat, Sarah
    Myers, David T.
    Shahzade, Heather A.
    Hong, Catriona
    Corcoran, Ryan B.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 76 - 76
  • [9] Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models
    Lee, Michael S.
    Helms, Timothy L.
    Feng, Ningping
    Gay, Jason
    Chang, Qing Edward
    Tian, Feng
    Wu, Ji Y.
    Toniatti, Carlo
    Heffernan, Timothy P.
    Powis, Garth
    Kwong, Lawrence N.
    Kopetz, Scott
    ONCOTARGET, 2016, 7 (26) : 39595 - 39608
  • [10] Dual CDK4/ARK5 inhibition by ON 123300 for targeting metastatic colorectal cancer
    Reddy, M.
    Cosenza, Stephen
    Divakar, Saikrishna
    Akula, Balireddy
    Mallireddigari, Muralidhar
    Reddy, Premkumar
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
12345